MedTrace Logo

Daytime Corneal Swelling During Wear of Narafilcon B Lenses

NCT01444287 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2018-06-19

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to measure daytime open-eye response to wearing of narafilcon B lenses.

Conditions

  • Myopia

Interventions

DEVICE

narafilcon B

test product

DEVICE

Polymacon

marketed product

DEVICE

Lotrafilcon A

marketed product

OTHER

Spectacles

None - subject used own spectacles

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Principal Investigators

  • Noel Brennan, McOptom PhD · Coles-Brennan Pty Ltd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-02-28
Completion
2010-03-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01444287 on ClinicalTrials.gov